American Shared Hospital Services (AMS) vs BioNexus Gene Lab (BGLC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
American Shared Hospital Services is the larger company by market cap ($9.0 million vs $3.9 million), about 2.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AMS | BGLC |
|---|---|---|
| Share price | $1.35 | $1.34 |
| Market cap | $8.98M | $3.93M |
| 1-day change | -2.17% | +6.77% |
| EPS (TTM) | $-0.26 | $-1.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.48 | $5.89 |
| 52-week low | $1.25 | $1.07 |
| Distance from 52-week high | -45.56% | -77.24% |
| Average volume | 14.83K | 10.82K |
| Shares outstanding | 6.65M | 2.93M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- American Shared Hospital Services is about 2.3 times larger than BioNexus Gene Lab by market value ($8.98M vs $3.93M).
AMS vs BGLC FAQ
Which is bigger, American Shared Hospital Services or BioNexus Gene Lab?
American Shared Hospital Services (AMS) is larger, with a market capitalization of $8.98M compared with $3.93M for BioNexus Gene Lab (BGLC).
Are American Shared Hospital Services and BioNexus Gene Lab in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.